Wednesday, December 04, 2019 2:41:56 PM
6.00 p.m LB7 - One-month oral treatment with PTI-125, a new drug candidate, reduces CSF and plasma biomarkers of Alzheimer’s disease
Lindsay BURNS (1), Hoau-Yan WANG (2), Zhe PEI (2), Kuo-Chieh LEE (2), Carrie CROWLEY (2), Michael MARSMAN (2),
Nadav FRIEDMANN (2)
(1) Cassava Sciences, Inc., United States, (2) City of New York School of Medicine, United States
Recent SAVA News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 01:10:10 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/04/2024 09:09:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 12:10:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 08:37:36 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/01/2024 08:07:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 11:36:59 AM
- Cassava Sciences Resolves SEC Investigation • GlobeNewswire Inc. • 09/26/2024 10:15:00 PM
- Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials • GlobeNewswire Inc. • 09/24/2024 12:30:00 PM
- Cassava Sciences Names Rick Barry as Chief Executive Officer • GlobeNewswire Inc. • 09/09/2024 12:30:00 PM
- Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 12:31:00 PM
- Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates • GlobeNewswire Inc. • 08/08/2024 12:00:00 PM
- Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson • GlobeNewswire Inc. • 08/05/2024 01:01:00 PM
- Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET • GlobeNewswire Inc. • 08/01/2024 12:30:00 PM
- Cassava Sciences Announces Expansion of Open-Label Extension Trials • GlobeNewswire Inc. • 07/30/2024 12:15:00 PM
- Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives • GlobeNewswire Inc. • 07/17/2024 12:00:00 PM
- Cassava Sciences Issues Statement on Former Science Advisor • GlobeNewswire Inc. • 06/28/2024 07:58:09 PM
- Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam • GlobeNewswire Inc. • 05/10/2024 08:02:00 PM
- Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution • GlobeNewswire Inc. • 05/08/2024 03:00:00 PM
- Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ • GlobeNewswire Inc. • 05/01/2024 01:10:00 PM
- Redemption Date Announced for Warrants • GlobeNewswire Inc. • 04/15/2024 01:20:00 PM
- Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials • GlobeNewswire Inc. • 03/25/2024 01:13:00 PM
- Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference • GlobeNewswire Inc. • 03/04/2024 02:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 09:01:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 02:22:12 PM
- Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates • GlobeNewswire Inc. • 02/28/2024 02:14:00 PM
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • Nov 7, 2024 8:48 AM
FEATURED SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • Nov 7, 2024 7:00 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM